AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34315611 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV20
Number of subjects: 1710
Study 34315611 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 1710
Study 34307194 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive COX-2 inhibitor (etoricoxib)
Number of subjects: 39
Study 34307194 — intervention group
Group type: COMPARATOR
Intervention: Standard TB treatment without COX-2 inhibitor
Number of subjects: 39
Study 32114523 — intervention group
Group type: EXPERIMENTAL
Intervention: Drospirenone 4 mg film-coated tablet, 24 days active treatment followed by 4 days placebo, for 13 cycles of 28 days each
Number of subjects: 21
Study 34022122 — intervention group
Group type: EXPERIMENTAL
Intervention: Recorded lullabies
Number of subjects: 90
Study 34022122 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's live lullabies
Number of subjects: 90
Study 34022122 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study 32522883 — intervention group
Group type: EXPERIMENTAL
Intervention: Equal payment distribution
Number of subjects: 443
Study 32522883 — intervention group
Group type: COMPARATOR
Intervention: Unequal payment distribution
Number of subjects: 443
Study 32522883 — intervention group
Group type: EXPERIMENTAL
Intervention: Payment size increase
Number of subjects: 443
Study 32522883 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender comparison
Number of subjects: 443
Study 35507959 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively Based Compassion Training (CBCT®), n=34
Number of subjects: 65
Study 35507959 — intervention group
Group type: COMPARATOR
Intervention: Control group, n=31
Number of subjects: 65
Study 35392886 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized non-face-to-face primary dental care using the V4H platform
Number of subjects: 368
Study 35392886 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group (control)
Number of subjects: 368
Study 33630834 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically decreased vitamin D levels (measured as 25-hydroxyvitamin D, 25OHD)
Number of subjects: 24063
Study 33630834 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleiotropy robust MR methods
Number of subjects: 24063
Study 33630834 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity analyses excluding SNPs associated with serum lipid levels, body composition, blood traits, and type 2 diabetes
Number of subjects: 24063
Study 32236329 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised group (SG)
Number of subjects: 0
Study 32236329 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised group (WG)
Number of subjects: 0
Study 32236329 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study 35053999 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma Releasate (PRPr)
Number of subjects: 16
Study 35053999 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid (CS)
Number of subjects: 16
Study 32173637 — intervention group
Group type: EXPERIMENTAL
Intervention: Puerarin combined with naloxone
Number of subjects: 52
Study 32173637 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 52
Study 36423240 — intervention group
Group type: EXPERIMENTAL
Intervention: PCC4 (30 units/kg) administered intraoperatively
Number of subjects: 35
Study 33733688 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung CT Screening Reporting and Data System (Lung‐RADS) categorisation by fellowship-trained thoracic radiologists
Number of subjects: 162
Study 33733688 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced thoracic radiologists
Number of subjects: 162
Study 33733688 — intervention group
Group type: EXPERIMENTAL
Intervention: Part‐solid risk‐dominant nodules
Number of subjects: 162
Study 32988371 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning (n = 25)
Number of subjects: 49
Study 32988371 — intervention group
Group type: COMPARATOR
Intervention: Traditional face-to-face approach (n = 24)
Number of subjects: 49
Study 32797085 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT)
Number of subjects: 8069
Study 32797085 — intervention group
Group type: COMPARATOR
Intervention: Color fundus photography (CFP)
Number of subjects: 8069
Study 34320555 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person clinic visit
Number of subjects: 30
Study 34320555 — intervention group
Group type: COMPARATOR
Intervention: Telehealth clinic visit
Number of subjects: 30
Study 36109167 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 32
Study 36109167 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 32
Study 36109167 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 32
Study 36109167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 33085551 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative research integration into clinical trials
Number of subjects: 0
Study 33085551 — intervention group
Group type: EXPERIMENTAL
Intervention: Framework for integrating qualitative research
Number of subjects: 0
Study 35705913 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (rt-PA) for acute ischemic stroke
Number of subjects: 0
Study 35705913 — intervention group
Group type: COMPARATOR
Intervention: Sensitivity analyses based on randomization process
Number of subjects: 0
Study 35705913 — intervention group
Group type: COMPARATOR
Intervention: Baseline characteristics and CT results
Number of subjects: 0
Study 32348263 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer app with structured information delivery, personalized physical activity prescription, and follow-up on number of steps per day
Number of subjects: 98
Study 32348263 — intervention group
Group type: COMPARATOR
Intervention: Pedometer app with daily walking goal of 10,000 steps
Number of subjects: 98
Study 36112590 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra virgin coconut oil (EVCO) 25 g
Number of subjects: 20
Study 36112590 — intervention group
Group type: COMPARATOR
Intervention: Extra virgin olive oil (EVOO) 25 g
Number of subjects: 20
Study 36112590 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum energy intake after EVCO
Number of subjects: 20
Study 36112590 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum energy intake after EVOO
Number of subjects: 20
Study 34075589 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (8 mg/kg intravenous, weeks 0, 4, and 8)
Number of subjects: 22
Study 34075589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 34075589 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 22
Study 36197183 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion at 7 to 9 am
Number of subjects: 90
Study 36197183 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion at 5 to 7 pm
Number of subjects: 90
Study 36197183 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group (control)
Number of subjects: 90
Study 34425071 — intervention group
Group type: EXPERIMENTAL
Intervention: Selonsertib 2 mg
Number of subjects: 151
Study 34425071 — intervention group
Group type: EXPERIMENTAL
Intervention: Selonsertib 6 mg
Number of subjects: 151
Study 34425071 — intervention group
Group type: EXPERIMENTAL
Intervention: Selonsertib 18 mg
Number of subjects: 151
Study 34425071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 33982167 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) using glass ionomer cement (KetacTM Molar Easymix)
Number of subjects: 25
Study 33982167 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART)
Number of subjects: 25
Study 36472135 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb loading training (LLLT) with augmented feedback
Number of subjects: 44
Study 36472135 — intervention group
Group type: COMPARATOR
Intervention: Lower limb loading training (LLLT) without augmented feedback
Number of subjects: 44
Study 32166878 — intervention group
Group type: EXPERIMENTAL
Intervention: Brassica juncea feeding for 6 hours
Number of subjects: 0
Study 32166878 — intervention group
Group type: EXPERIMENTAL
Intervention: Brassica juncea feeding for 48 hours
Number of subjects: 0
Study 32071058 — intervention group
Group type: EXPERIMENTAL
Intervention: Presatovir
Number of subjects: 382
Study 32071058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 382
Study 35190503 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Communication Study
Number of subjects: 377
Study 33639957 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast track surgery (FTS)
Number of subjects: 8886
Study 34001204 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri-Lock Bone Preservation Stem
Number of subjects: 90
Study 34001204 — intervention group
Group type: EXPERIMENTAL
Intervention: Minima S stem
Number of subjects: 90
Study 34244749 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological and nonpharmacological interventions (specifics not provided)
Number of subjects: 0
Study 34244749 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 0
Study 34657018 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine®
Number of subjects: 50
Study 34657018 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 50
Study 34657018 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium Hydroxide (CH)
Number of subjects: 50
Study 34657018 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Biodentine, MTA, CH)
Number of subjects: 50
Study 32056061 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion regulation training (8 sessions of 90 minutes each)
Number of subjects: 70
Study 32056061 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 33419872 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-valent pneumococcal conjugate vaccine (PCV9)
Number of subjects: 39836
Study 33419872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39836
Study 32320007 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital cognitive behavioral therapy
Number of subjects: 0
Study 32320007 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35279300 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% DMSO pretreatment with Single Bond 2 (SB2)
Number of subjects: 3
Study 35279300 — intervention group
Group type: COMPARATOR
Intervention: Deionized water with Single Bond 2 (SB2)
Number of subjects: 3
Study 35279300 — intervention group
Group type: EXPERIMENTAL
Intervention: DMSO pretreatment
Number of subjects: 3
Study 35279300 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonding steps
Number of subjects: 3
Study 32039876 — intervention group
Group type: EXPERIMENTAL
Intervention: Real iTBS
Number of subjects: 30
Study 32039876 — intervention group
Group type: COMPARATOR
Intervention: Sham iTBS
Number of subjects: 30
Study 33970042 — intervention group
Group type: EXPERIMENTAL
Intervention: CaneCPI-5 (0.1 mg/mL)
Number of subjects: 15
Study 33970042 — intervention group
Group type: EXPERIMENTAL
Intervention: SnCl2/NaF/AmF (Elmex; positive control)
Number of subjects: 15
Study 33970042 — intervention group
Group type: COMPARATOR
Intervention: Water (negative control)
Number of subjects: 15
Study 32046669 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention based on Cognitive Behavioral Therapy (n=120)
Number of subjects: 120
Study 32046669 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WL, n=120)
Number of subjects: 120
Study 35346041 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 49
Study 35346041 — intervention group
Group type: COMPARATOR
Intervention: Propofol (PRO)
Number of subjects: 49
Study 33837097 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) consisting of four online group sessions and online support over 8 weeks
Number of subjects: 30
Study 33837097 — intervention group
Group type: COMPARATOR
Intervention: Baseline phase of 14-28 days before MBI
Number of subjects: 30
Study 32050198 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen-enriched air (FiO2 0.5)
Number of subjects: 20
Study 32050198 — intervention group
Group type: COMPARATOR
Intervention: Ambient air (FiO2 0.21)
Number of subjects: 20
Study 32250836 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resistance training program (5 sessions/week for 9 weeks)
Number of subjects: 37
Study 33220397 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A (AA) with FOLFOX x6 cycles prior to high dose rate brachytherapy (HDRBT) and surgery plus adjuvant FOLFOX x6 cycles
Number of subjects: 180
Study 33220397 — intervention group
Group type: COMPARATOR
Intervention: Arm B (AB) with neoadjuvant HDRBT with surgery and adjuvant FOLFOX x12 cycles
Number of subjects: 180
Study 33220397 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A (AA)
Number of subjects: 180
Study 33220397 — intervention group
Group type: COMPARATOR
Intervention: Arm B (AB)
Number of subjects: 180
Study 32941801 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 198
Study 32941801 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaccination
Number of subjects: 198
Study 36402730 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable technology (Fitbit Charge 2) with goal setting and text message feedback
Number of subjects: 0
Study 36402730 — intervention group
Group type: COMPARATOR
Intervention: Wearable technology alone (active comparator)
Number of subjects: 0
Study 33499569 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional carbon dioxide laser combined with autologous fat injection
Number of subjects: 12
Study 33499569 — intervention group
Group type: COMPARATOR
Intervention: Laser alone
Number of subjects: 12
Study 32912292 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-arm assisted total hip arthroplasty (RO THA)
Number of subjects: 60
Study 32912292 — intervention group
Group type: COMPARATOR
Intervention: Conventional manual total hip arthroplasty (CO THA)
Number of subjects: 60
Study 36214144 — intervention group
Group type: COMPARATOR
Intervention: Basal analgesia: midazolam (1 mg), fentanyl (0.05 mg), dexketoprofen (50 mg)
Number of subjects: 80
Study 36214144 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal analgesia and nitrous oxide
Number of subjects: 80
Study 36214144 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal analgesia and music
Number of subjects: 80
Study 36214144 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal analgesia, nitrous oxide and music
Number of subjects: 80
Study 36214144 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study 36214144 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients younger than 50 years
Number of subjects: 80
Study 33415406 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatrists experiencing patient suicide
Number of subjects: 324
Study 33415406 — intervention group
Group type: EXPERIMENTAL
Intervention: Trainees experiencing patient suicide
Number of subjects: 324
Study 32217148 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleoylethanolamide (OEA)
Number of subjects: 76
Study 32217148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 36266163 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth intervention
Number of subjects: 150
Study 36266163 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 34246602 — intervention group
Group type: EXPERIMENTAL
Intervention: Early multidomain rehabilitation intervention
Number of subjects: 349
Study 34022103 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacilli (SynForU‐HerCare; two capsules/day of 9·5 log CFU per capsule)
Number of subjects: 78
Study 34022103 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacilli
Number of subjects: 78
Study 34022103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 32590220 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentive programmes with varying amounts (US$106.19 to $4,027.92)
Number of subjects: 26
Study 32590220 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparisons to reduce between-study variations
Number of subjects: 26
Study 32590220 — intervention group
Group type: EXPERIMENTAL
Intervention: Further analyses for non-linear fits and changes in inflection
Number of subjects: 26
Study 33766837 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal glucose tolerance (NGT) group
Number of subjects: 895
Study 33766837 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired glucose regulation (IGR) group
Number of subjects: 895
Study 33766837 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 895
Study 35527324 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal analgesia (MMA) protocol including pregabalin, tramadol, wound infiltration, and transversus abdominis plane block
Number of subjects: 97
Study 35527324 — intervention group
Group type: COMPARATOR
Intervention: Morphine-based patient-controlled analgesia (PCA)
Number of subjects: 97
Study 32138501 — intervention group
Group type: EXPERIMENTAL
Intervention: Treprostinil (8‐12 ng/kg·min)
Number of subjects: 80
Study 32138501 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 80
Study 32566061 — intervention group
Group type: EXPERIMENTAL
Intervention: Orem's self-care model
Number of subjects: 130
Study 32566061 — intervention group
Group type: COMPARATOR
Intervention: Traditional care model
Number of subjects: 130
Study 33461302 — intervention group
Group type: EXPERIMENTAL
Intervention: AT/ET ratio ≥0.32
Number of subjects: 1530
Study 33461302 — intervention group
Group type: EXPERIMENTAL
Intervention: AT/ET ratio >0.32 in patients with low-gradient severe AS
Number of subjects: 1530
Study 35730409 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 40
Study 35730409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34990169 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Worker Health intervention
Number of subjects: 704
Study 32511707 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 506
Study 33460466 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem cell transplantation (ASCT)
Number of subjects: 136
Study 33460466 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib
Number of subjects: 136
Study 35738617 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum coated fabric
Number of subjects: 174
Study 35738617 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aluminum coated fabric with cotton swaddle
Number of subjects: 174
Study 35738617 — intervention group
Group type: COMPARATOR
Intervention: Cotton swaddle
Number of subjects: 174
Study 32170453 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-row fixation (Group I)
Number of subjects: 50
Study 32170453 — intervention group
Group type: COMPARATOR
Intervention: Double-row fixation (Group II)
Number of subjects: 50
Study 33769020 — intervention group
Group type: EXPERIMENTAL
Intervention: IncobotulinumtoxinA
Number of subjects: 64
Study 33769020 — intervention group
Group type: COMPARATOR
Intervention: OnabotulinumtoxinA
Number of subjects: 64
Study 34296667 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained bystanders
Number of subjects: 96
Study 34296667 — intervention group
Group type: COMPARATOR
Intervention: Dispatch doctors
Number of subjects: 96
Study 34296667 — intervention group
Group type: COMPARATOR
Intervention: Medical dispatch assistants
Number of subjects: 96
Study 34296667 — intervention group
Group type: COMPARATOR
Intervention: Untrained bystanders
Number of subjects: 96
Study 33142467 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/kg SB
Number of subjects: 288
Study 33142467 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/kg SB
Number of subjects: 288
Study 33142467 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,200 mg/kg SB
Number of subjects: 288
Study 33142467 — intervention group
Group type: EXPERIMENTAL
Intervention: SB supplementation
Number of subjects: 288
Study 33142467 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 288
Study 33428625 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT) plus treatment as usual (TAU)
Number of subjects: 256
Study 33428625 — intervention group
Group type: COMPARATOR
Intervention: Wait List+TAU
Number of subjects: 256
Study 32123205 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (n=23)
Number of subjects: 45
Study 32123205 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=22)
Number of subjects: 45
Study 32123205 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (n=20)
Number of subjects: 45
Study 35786581 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive group (n=50) - administered 600 mg of ibuprofen 1 hour before the procedure
Number of subjects: 100
Study 35786581 — intervention group
Group type: COMPARATOR
Intervention: Preventive group (n=50) - administered placebo preoperatively
Number of subjects: 100
Study 34133859 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted hypothermia at 33°C
Number of subjects: 1900
Study 34133859 — intervention group
Group type: COMPARATOR
Intervention: Targeted normothermia with early treatment of fever (body temperature, ≥37.8°C)
Number of subjects: 1900
Study 32430027 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) treatment, 1 to 3 treatment cycles
Number of subjects: 26
Study 32430027 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA) treatment
Number of subjects: 26
Study 32430027 — intervention group
Group type: COMPARATOR
Intervention: Control group (without fibroids)
Number of subjects: 26
Study 34132234 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed drill guides
Number of subjects: 0
Study 34132234 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular guides
Number of subjects: 0
Study 34132234 — intervention group
Group type: COMPARATOR
Intervention: Additional screw guiding methods (k-wire cannulated screws or modular guides)
Number of subjects: 0
Study 34132234 — intervention group
Group type: COMPARATOR
Intervention: Regular 3D-printed drill guides
Number of subjects: 0